Mercedes Prudencio

Has grant

Associate Professor

Mayo Clinic

United States

Research Interests

Explore related searches

Professors in United States Professors in Medical Science Medical Science professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Mercedes Prudencio is an Associate Professor at Mayo Clinic in the United States. Her research focuses on neurodegenerative diseases, including spinocerebellar ataxia and frontotemporal dementia. Recent publications highlight her work on potential biomarkers for ALS and FTD, as well as the role of TDP-43 in these conditions.

Recent Grants

Grant: Close

Discovery of novel TDP-43 splicing targets: the Achilles heel for FTD and towards sensitive biomarkers and therapeutic targets

Open Date: 2021-09-15

Close Date: 2026-08-31

Grant: Close

Stathmin-2 and TDP-43 neurodegeneration in Alzheimer’s and multi-etiology dementias

Open Date: 2021-04-01

Close Date: 2024-03-31

Articles (12)

Year:

2025

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Collaborators (8)

Yuka Koike

Assistant professor

Niigata University

JAPAN

View details

Jonathan Rohrer

University College London

UNITED KINGDOM

View details

Zbigniew K. Wszolek

Professor of Neurology

Mayo Clinic Florida

UNITED STATES

View details

Manuela Lima

Professora Catedrática (Full Professor)

University of the Azores

PORTUGAL

View details

Raoul Sutter

SWITZERLAND

View details

Sarah Kargbo-Hill

Assistant Professor

University of Michigan

UNITED STATES

View details

Anna-Leigh Brown

University College London

UNITED KINGDOM

View details

Shan Ali

Medical University of Gdansk

POLAND

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Mercedes Prudencio

Research Interests

Explore related searches

Contact this professor

About

Recent Grants

Articles (12)

Evaluating Glial Fibrillary Acidic Protein and Neurofilament Light as Potential Biomarkers for Spinocerebellar Ataxia 7

Mis-spliced transcripts generate de novo proteins in TDP-43-related ALS/FTD.

Perry syndrome: Novel DCTN1 mutation in a large kindred and first observation of prodromal disease

Prognostic performance of blood neurofilament light chain protein in hospitalized COVID-19 patients without major central nervous system manifestations: an individual participant data meta-analysis

Author Correction: Toxic expanded GGGGCC repeat transcription is mediated by the PAF1 complex in C9orf72-associated FTD

Tau and neurofilament light-chain as fluid biomarkers in spinocerebellar ataxia type 3

Evidence of cerebellar TDP-43 loss of function in FTLD-TDP

Two FTD-ALS genes converge on the endosomal pathway to induce TDP-43 pathology and degeneration

TDP-43 represses cryptic exon inclusion in the FTD–ALS gene UNC13A

Poly(GR) and poly(GA) in cerebrospinal fluid as potential biomarkers for C9ORF72-ALS/FTD.

Microglial lysosome dysfunction contributes to white matter pathology and TDP-43 proteinopathy in GRN-associated FTD.

Urine levels of the polyglutamine ataxin-3 protein are elevated in patients with spinocerebellar ataxia type 3.

Collaborators (8)

Yuka Koike

Jonathan Rohrer

Zbigniew K. Wszolek

Manuela Lima

Raoul Sutter

Sarah Kargbo-Hill

Anna-Leigh Brown

Shan Ali

Make your next move.